摘要
目的观察顽痹泰颗粒剂治疗类风湿关节炎(Rheumatoid Arthritis,RA)的临床疗效。方法 60例RA患者随机分为2组,治疗组予甲氨蝶呤和顽痹泰颗粒剂,对照组予口服甲氨蝶呤片,比较2组治疗后各项疗效评价指标的改善情况,并记录不良反应。结果治疗组统计疗效结果明显优于对照组,治疗组不良反应发生率明显低于对照组,差异有统计学意义(P<0.05)。结论顽痹泰颗粒剂治疗类风湿关节炎有较好的疗效。
Objective To evaluate the clinical effect of Wanbitai granule in treating rheumatoid arthritis （RA） . Methods 60 cases of patients were randomized into two groups. The treatment group was given Wanbitai granule and MTX. The control group was given MTX. The signs, symptoms and bio-chemieal results of patients after treatment were observed. The adverse reaction was recorded. Results The therapeutic effect of the treatment group was better than that of the control group. The incidence rate of adverse reaction of the treatment group was less than those of the control group （P〈0.05） . Conclusion Wanbitai granule in treating RA has good therapeutic effect.
出处
《中国中医药现代远程教育》
2017年第12期103-105,共3页
Chinese Medicine Modern Distance Education of China
关键词
类风湿关节炎
顽痹泰颗粒剂
中医药疗法
中成药疗法
痹证
rheumatoid arthritis
Wanbitai granule
therapy of TCM
therapy of Chinese patent drug
arthromyodynia
